Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

LABSOURCE LLC

NPI: 1801155106 · GREENVILLE, SC 29607 · Clinical Medical Laboratory · NPI assigned 05/08/2012

$900K
Total Medicaid Paid
36,260
Total Claims
32,403
Beneficiaries
33
Codes Billed
2018-01
First Month
2019-08
Last Month

Provider Details

Authorized OfficialMCCOLLUM, DANIEL (OWNER)
NPI Enumeration Date05/08/2012

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 25,585 $690K
2019 10,675 $209K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 8,517 6,939 $420K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 8,872 8,015 $200K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 3,203 2,983 $100K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 763 446 $73K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 1,333 1,203 $71K
80373 618 572 $3K
80372 581 555 $3K
80367 589 562 $3K
80355 549 523 $3K
80366 548 522 $3K
80369 486 476 $2K
80323 485 461 $2K
80375 337 326 $2K
80346 616 570 $2K
80361 624 577 $1K
83992 580 554 $1K
80348 623 576 $804.02
80358 624 577 $803.98
80354 624 577 $803.84
80353 600 561 $802.26
80359 581 555 $802.26
80325 579 553 $802.26
80356 581 555 $802.26
80365 623 576 $761.56
80364 472 464 $747.43
80349 549 524 $706.77
80360 516 508 $648.41
80352 459 451 $510.48
80371 481 467 $468.04
80370 93 75 $392.70
80363 82 64 $391.76
80368 36 18 $69.00
80338 36 18 $69.00